Skip to main content
. 2022 Oct 14;23:e937128-1–e937128-4. doi: 10.12659/AJCR.937128

Table 1.

The timeline of reverse agent administration in the emergence phase. Reverse agent dosage was 0.2 mg of glycopyrrolate for every 1 mg of neostigmine.

Timeline Reversal agent (dose) Train-of-four ratio
0 min Neostigmine 3 mg 16%
15 min Neostigmine 2 mg 25%
30 min Neostigmine 1 mg 25%
40 min Sugammadex 200 mg 105%